Degree of protection in the Malta Scheduled Property Register.
1Two patients developed grade 3 proteinuria that resolved after a treatment break.
2The commonest post-operative diagnosis was CIN grade 3 in all age groups.
3Dose-limiting toxicities were defined as grade 3 esophageal, cardiac, or pulmonary toxicity.
4MRC grade 3 is a critical point of indication for application of MEPs.
5The incidence of any- grade and grade 3 or greater adverse events was manageable.
6The incidence of grade 3 or higher toxicities was greater with combination therapy.
7No grade 3 or important clinical, hematologic, or biochemical toxicities occurred.
8Nodal involvement was associated with serous histology and grade 3 tumor.
9Dose-related grade 3 fatigue and vomiting were observed but these were not dose-limiting.
10Only one grade 3 of subacute toxicity for thrombocytopenia was noted.
11This component was diagnostic of grade 3 papillary renal cell carcinoma.
12No grade 3+ adverse events potentially related to study medication were observed.
13PCI was also associated with a modest increase in grade 3 or higher AEs.
14No grade 3 or higher hematologic adverse events were observed.
15No patients developed late grade 3 GI or GU toxicity.
16One patient was taken off study for grade 3 neuropathy.